European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

6 EU fundings (total €444,766): BetaCure Personalized Diagnosis and Treatment of Hyperinsulinemic Hypoglycaemia Caused by Beta-Cell Pathology 602812 … BdlYear 2014 Financial Transparency System

Text

CONCENTRIS Research Management GmbH, Fürstenfeldbruck, Germany

01/04/2014 EU funding: BetaCure Personalized Diagnosis and Treatment of Hyperinsulinemic Hypoglycaemia Caused by Beta-Cell Pathology 602812
01/04/2014 EU funding: BetaCure Personalized Diagnosis and Treatment of Hyperinsulinemic Hypoglycaemia Caused by Beta-Cell Pathology 602812
01/03/2014 EU funding: Matrics
01/03/2014 EU funding (€10,542.16): Health-F2-2013-603016 - Matrics
01/02/2014 EU funding (€360,000): Grant FP7 - 602442 - Milestone
01/03/2014 EU funding (€74,224): Health-F2-2013-603016 - Matrics

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: CONCENTRIS Research Management GmbH, Fürstenfeldbruck, Germany.

Creative Commons License The visualizations for "CONCENTRIS Research Management GmbH - 6 EU fundings (total €444,766): BetaCure Personalized Diagnosis and Treatment of Hyperinsulinemic Hypoglycaemia Caused by Beta-Cell Pathology 602812 …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close